Pulse Biosciences, Inc.
PLSE • NASDAQ
Pulse Biosciences, Inc. is a medical - instruments & supplies company in the healthcare sector trading on NASDAQ, led by CEO Paul Arthur LaViolette, with a market cap of $1.3B.
Market Cap$1.3B
Employees56.0
CEOPaul Arthur LaViolette
CountryUnited States of America
Healthcare
Medical - Instruments & Supplies
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
PLS
Pulse Biosciences, Inc. FAQ
Common questions about Pulse Biosciences, Inc.
Pulse Biosciences, Inc. is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $440.0K.
Pulse Biosciences, Inc. has approximately 56 employees.